article · Clinical Infectious Diseases

Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana

James Milburn
Tony Chebani
Samuel Ensor
Madisa Mine
Matthew Kinsella
Mark W. Tenforde
Imogen Mechie
David S. Lawrence
James Penney
Tshepo Leeme
Ookeditse Ntwayagae
Dinah Ramaabya
Ava Avalos
Kebatshabile Ngoni
Rachita Suresh
Goitseone Thamae
Daniel Grint
Cassie Northcott
Justus Ogando
Margaret Mokomane
Joseph N Jarvis

20249 citationsOpen accessUniversity of Botswana

Abstract

CM incidence has decreased in Botswana following expansion of ART coverage but persists at a stubbornly high incidence. Most cases are now diagnosed through the cheap and easy-to-use cryptococcal antigen test, highlighting the potential of using CM as key metric of program success in the Treat All era.

Research topics

Fungal Infections and Studies
Antifungal resistance and susceptibility
HIV/AIDS oral health manifestations

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1093/cid/ciae066

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.